Skip to main content
Clinical Trials/NCT03229330
NCT03229330CompletedNot Applicable

The Effect of Low-level Light Therapy on Treatment of Venous Ulcers Assessed by Nursing Outcomes Classification (NOC): Randomized Clinical Trial

Hospital de Clinicas de Porto Alegre1 site in 1 country40 target enrollmentStarted: April 1, 2016Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
40
Locations
1
Primary Endpoint
Decreased Wound Size and Scar formation

Study Overview

Brief Summary

This study compares the effect of adjuvant treatment of Low-level Light Therapy with conventional treatment in the tissue repair of venous ulcers in patients undergoing outpatient nursing consultation. For the evaluation of the cases clinical indicators of Nursing Outcomes Classification have been used.

Detailed Description

There are several therapeutics with different mechanisms of action to reach tissue repair.

The conventional treatment of venous ulcers is based on the alternation of exercising the lower extremities with resting, the application of topical treatments associated with compressive therapy, and the use of medications.

Despite the diversity of bandages available, there are still lesions with difficult prolonged healing process. Therefore, Low-level Light Therapy has been used as an adjuvant technological alternative therapy, due to its photochemical effects on the tissues, such as the modulation of inflammation, increase of granulation tissue, contraction of the wound, reduction of the inflammatory process, and reduction of pain. This therapy contributes to accelerate and improve the tissue repair process.

Studies assessed by Nursing Outcomes Classification about the usage of the treatments above combined are not available. Consequently, more robust clinical studies over venous ulcers to evaluate the tissue repair must be proposed using reliable instruments.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Masking Description

All subjects involved are aware of the procedures applied due to the features of the therapies used.

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Presence of venous ulcer
  • •Availability for weekly appointment
  • •Acceptance to participate of the research with the signature of the Term of Free and Informed Consent

Exclusion Criteria

  • •Morbid obesity
  • •Active cancer treatment
  • •Erysipelas
  • •Cellulitis, lymphangitis and chronic lymphedema
  • •Usage of immunosuppressants and / or corticosteroids
  • •Venous ulcer all around the leg
  • •Presence of coagulation necrosis covering more than 25% of the wound bed.

Arms & Interventions

Intervention

Experimental

Low-level Light Therapy: Wavelength of 660 nm (red laser) and Conventional treatment: Topical treatment with compressive therapy, exercises of lower extremities, resting; once a week for 16 weeks.

Intervention: Low-level Light Therapy (Procedure)

Intervention

Experimental

Low-level Light Therapy: Wavelength of 660 nm (red laser) and Conventional treatment: Topical treatment with compressive therapy, exercises of lower extremities, resting; once a week for 16 weeks.

Intervention: Conventional treatment (Combination Product)

Controls

Active Comparator

Conventional treatment: Topical treatment with compressive therapy, exercises of lower extremities, resting; once a week for 16 weeks.

Intervention: Conventional treatment (Combination Product)

Outcomes

Primary Outcomes

Decreased Wound Size and Scar formation

Time Frame: 16 weeks

NOC Wound Healing: Second Intention - Greater length (in the cephalopheudial direction) versus greater width, in cm2 evaluated by the Likert scale, being 1 the worst score and 5 best score. NOC Wound Healing: Second Intention - Wound covered with epithelial tissue (new pink or bright tissue that develops from the edges or as "islands" on the surface of the lesion) evaluated by the Likert scale, being 1 the worst score and 5 best score.

Secondary Outcomes

  • Skin thickness(16 weeks)
  • Evaluation of Pain(16 weeks)
  • Overall improvement of other NOC indicators correlated.(16 weeks)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials